Medtech company Enovis has tapped Damien McDonald as its new CEO, taking over the role on May 21.
Mr. McDonald will succeed Matt Trerotola, who recently announced plans to retire, according to an April 2 company news release.
Mr. McDonald has more than 35 years of experience in the medical device industry, most recently serving as CEO of LivaNova.
Enovis projects first-quarter revenue between $555 million and $563 million and an adjusted EBITDA in the range of $97 million to $100 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
